News PRESS RELEASES Featured January 9, 2026 Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases January 9, 2026 Read more → January 9, 2026 IN THE NEWS Featured March 1, 2026 Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye March 1, 2026 Cell & Gene Read more → March 1, 2026 February 17, 2026 Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That. February 17, 2026 Forbes Read more → February 17, 2026 February 12, 2026 Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more February 12, 2026 Biotech TV Read more → February 12, 2026 January 21, 2026 JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing January 21, 2026 Inside Precision Medicine Read more → January 21, 2026 January 9, 2026 Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies January 9, 2026 BioPharma Dive Read more → January 9, 2026 January 9, 2026 Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines January 9, 2026 STAT Read more → January 9, 2026 January 9, 2026 Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments January 9, 2026 Wired Read more → January 9, 2026 January 9, 2026 Gene editing pioneers launch first startup focused on custom CRISPR therapies January 9, 2026 Endpoints News Read more → January 9, 2026
